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In GENDEP, a European multicentre pharmacogenomic
study http://gendep.iop.kcl.ac.uk/results.php, subjects
with major depression were treated with escitalopram
(ESC) or nortriptyline (NOR), in a part-randomised
potential crossover design, and prospectively rated for
response and ADRs with measures including the
M A D R S ,H D R S ,B D I ,U K U ,a n dA S E C( as e l f - r e p o r t
measure developed for GENDEP, Uher et al, in press).
Factor analysis and Item Response Theory applied to
the three measures of depression employed in the study
generated three symptom dimensions. Mixed linear
regression models showed no difference between ESC
and NOR on the three original scales, but symptom
dimensions revealed drug-specific advantages: observed
mood and cognitive symptoms improved more with
ESC than with NOR; neurovegetative symptoms
improved more with NOR than with ESC. CYP2C19
genotypic category significantly predicted steady-state
(week 8) ESC concentration. Analysis of baseline weight
as a predictor revealed that lower BMI predicted better
response to NOR. There was good agreement between
the UKU and the ASEC, and urinary symptoms, dry
mouth, blurred vision, and orthostatic hypotension
predicted discontinuation of either drug.
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